Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Kiselev

Showing results (211-220 of 238) with videos related to

Pageof 24
Sort By:
Acta Naturae|January 25, 2013
Recombinant influenza vaccinesE S Sedova, D N Shcherbinin, A I Migunov, et al.
Gigiena I Sanitariia|March 1, 1995
[Effect of sanitary and hygienic conditions of populated placed on the incidence of intestinal diseases]V V Aleshnia, S V Golovina, P V Zhuravlev, et al.
Molekuliarnaia Biologiia|April 9, 2008
[Molecular characteristic of influenza virus A H5N1 Strains isolated from poultry in Kurgan Region in 2005]O I Kiselev, V M Blinov, M M Pisareva, et al.
Biomedical Science|January 1, 1990
Effective inhibition of viral reproduction by hydrophobised antiviral antibodiesA V Kabanov, A V Ovcharenko, N S Melik-Nubarov, et al.
Vaccine|May 16, 2015
Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2eLiudmila M Tsybalova, Liudmila A Stepanova, Victor V Kuprianov, et al.
Photodiagnosis and Photodynamic Therapy|July 23, 2014
Photodynamic inactivation of influenza virus with fullerene C60 suspension in allantoic fluidVladimir V Zarubaev, Inna M Belousova, Oleg I Kiselev, et al.
Bioorganicheskaia Khimiia|November 22, 2011
[A new method of producing biologically active nanocomplexes by non-covalent conjugation of proteins with viral particles]A A Iaroslavov, I V Kaplan, T N Erokhina, et al.
Voprosy Virusologii|March 13, 2013
[Characterization of cold-adapted influenza strain A/HongKong/1/68/162/35 as a potential donor of attenuation and high reproduction]L M Tsybalova, N E Gorev, M V Potapchuk, et al.
Current Pharmaceutical Design|February 12, 2013
Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectorsNatalia V Petukhova, Tatiana V Gasanova, Liudmila A Stepanova, et al.
Voprosy Onkologii|November 17, 2018
[Oncolytic potential of recombinant influenza A virus vectors on a model of malignant glioma in vivo]A P S Shurygina, A V Kartashev, E G Kovanko, et al.
Pageof 24

Showing results (211-220 of 238) with videos related to

Sort By:
Pageof 24
Acta Naturae|January 25, 2013
Recombinant influenza vaccinesE S Sedova, D N Shcherbinin, A I Migunov, et al.
Gigiena I Sanitariia|March 1, 1995
[Effect of sanitary and hygienic conditions of populated placed on the incidence of intestinal diseases]V V Aleshnia, S V Golovina, P V Zhuravlev, et al.
Molekuliarnaia Biologiia|April 9, 2008
[Molecular characteristic of influenza virus A H5N1 Strains isolated from poultry in Kurgan Region in 2005]O I Kiselev, V M Blinov, M M Pisareva, et al.
Biomedical Science|January 1, 1990
Effective inhibition of viral reproduction by hydrophobised antiviral antibodiesA V Kabanov, A V Ovcharenko, N S Melik-Nubarov, et al.
Vaccine|May 16, 2015
Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2eLiudmila M Tsybalova, Liudmila A Stepanova, Victor V Kuprianov, et al.
Photodiagnosis and Photodynamic Therapy|July 23, 2014
Photodynamic inactivation of influenza virus with fullerene C60 suspension in allantoic fluidVladimir V Zarubaev, Inna M Belousova, Oleg I Kiselev, et al.
Bioorganicheskaia Khimiia|November 22, 2011
[A new method of producing biologically active nanocomplexes by non-covalent conjugation of proteins with viral particles]A A Iaroslavov, I V Kaplan, T N Erokhina, et al.
Voprosy Virusologii|March 13, 2013
[Characterization of cold-adapted influenza strain A/HongKong/1/68/162/35 as a potential donor of attenuation and high reproduction]L M Tsybalova, N E Gorev, M V Potapchuk, et al.
Current Pharmaceutical Design|February 12, 2013
Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectorsNatalia V Petukhova, Tatiana V Gasanova, Liudmila A Stepanova, et al.
Voprosy Onkologii|November 17, 2018
[Oncolytic potential of recombinant influenza A virus vectors on a model of malignant glioma in vivo]A P S Shurygina, A V Kartashev, E G Kovanko, et al.
Pageof 24